用于戒烟的对话聊天机器人:以用户为中心的11步设计开发过程和随机对照试验的结果
Jonathan B Bricker1,2, Brianna Sullivan1, Kristin Mull1
1Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, United States.
在一项试点研究中,QuitBot是一款新的对话式聊天机器人,与短信程序相比,它显示了更高的戒烟率. 这一发展标志着通过聊天机器人提供的第一个大型基于语言模型的戒烟干预措施.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 行为科学是一种行为科学.
- 医疗保健中的人工智能
背景情况:
- 交谈式聊天机器人代表了戒烟的新兴数字干预.
- 没有先前的研究详细介绍了戒烟聊天机器人的完整开发过程.
研究的目的:
- 为 QuitBot 报告以用户为中心的设计开发过程和随机对照试验 (RCT) 结果,QuitBot 是一种用于戒烟的新型对话式聊天机器人.
- 与现有的数字干预相比,评估QuitBot的有效性和用户参与度.
主要方法:
- 一个为期四年的以用户为中心的设计过程,涉及需求评估,人格发展和代原型设计.
- 开发一个42天的对话计划,并对现有干预措施进行内容分析.
- 一个试点随机对照试验 (RCT) 来评估QuitBot的有效性,随后进行代改进,包括添加一个大语言模型 (LLM) 驱动的问答功能.
主要成果:
- 在试点RCT中,QuitBot显示了高用户参与度和显著更高的3个月戒断率 (63%),与SmokefreeTXT (38.5%) 相比.
- 聊天机器人的对话功能由LLM和11,000对的QnA库提供动力,有效地解决了用户提出的问题.
- 从Facebook Messenger向独立应用程序的过渡改善了由于间歇性屏蔽问题而导致的交付道.
结论:
- 这项发展导致了第一个基于LLM的戒烟计划,作为对话聊天机器人.
- 代测试和用户反导致了显著的改进,包括改进的交付道和核心LLM支持的对话功能.
- 这项研究强调了人工智能驱动的对话代理在戒烟干预措施中的潜力.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
相关概念视频
Drug Dependence
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
